US FDA approves Hanmi's ceftriaxone injection
With the approval of ceftriaxone injection, the company is poised to make quicker inroads to the U.S. market and plans to annually ex...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
